Thrombotic and Hemorrhagic Complications in Patients with Mechanical Heart Valve Prosthesis Attending an Anticoagulation Clinic

Summary

This study evaluated the advantage of an anticoagulation clinic in terms of the improvement of the clinical quality of oral anticoagulation (i.e. prevention of thromboembolism and low rate of hemorrhagic complications). The incidence of thromboembolic events and major hemorrhagic complications was assessed in a series of 271 patients on oral anticoagulation for mechanical heart valve prosthesis before and after their enrollment in our anticoagulation clinic from January 1987 to December 1990. Risk factors for hemostatic events were also analyzed. The incidence of major hemostatic complications was significantly lower when patients attended the clinic: 1.0 vs 4.9%/pt-yr for hemorrhage and 0.6 vs 6.6%/pt-yr for thrombosis. This depended on three main factors: better dose regulation of warfarin, continuous patient education and early identification of clinical conditions potentially at risk for thrombosis and hemorrhage. Only previous hemorrhagic or thromboembolic events were recognized as major risk factors for hemostatic complications.

In conclusion, our study shows that an anticoagulation clinic offers a real advantage to patients with mechanical heart valve prosthesis in terms of prevention of thromboembolic events and hemorrhagic complications.

• References

• 1 Loeliger EA, Broekmans AW. Optimal therapeutic anticoagulation. Hemostasis 1985; 15: 283-292
• 2 Saour JN, Sieck JO, Mamo LAR, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990; 322: 428-432
• 3 Altman R, Rouvier J, Gurfinkel E. et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991; 101: 427-431
• 4 Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-1875
• 5 Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 1966-1968
• 6 Charney R, Leddomado E, Rose DN, Fuster V. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol 1988; 18: 197-206
• 7 Vossepoel AM. User acceptance of a computer-assisted anticoagulant control system. Med Inf 1981; 6: 131-136
• 8 Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990; 20: 119-125
• 9 Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein by-pass grafts. Chest 1989; (Suppl. 85) 1075S-1175S
• 10 Wiegman H, Vossepoel AM. A computer program for long term anticoagulation control. Comp Progr Biomed 1977; 7: 71-84
• 11 Van den Besselaar AMHP, Van der Meer FJM, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in The Netherlands. Am J Clin Pathol 1988; 90: 685-690
• 12 Levine MN, Raskob G, Hirsh J. Hemorrhagic complications of longterm anticoagulant therapy. Chest 1986; (Suppl. 89) 16S-35S
• 13 Schlesselman JJ. Case-Control Studies. Design, Conduct, Analysis. Oxford University Press; New York: 1982
• 14 Colton T. Statistics in Medicine. Boston MA. Little Brown; 1974
• 15 Bland M. An Introduction to Medical Statistics. Oxford Medical Publications; New York, Oxford: 1987
• 16 Cox DR. Regression models and life tables. J R Stat Soc 1972; 34 Ser B 187-220
• 17 Kurtzke JF. On estimating survival; a tale of two censors. J Clin Epidemiol 1989; 42: 169-175
• 18 Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic complications of mechanical heart valve prostheses. A meta-analysis. Thromb Haemostas 1991; 65 Suppl 1352
• 19 Duxbury BMcD. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 702-704
• 20 Kumar S, Haigh JRM, Rhodes LE. et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemostas 1989; 62: 729-732
• 21 Standing Advisory Committee for Haematology of the Royal College of Pathologists. Drug interactions with coumarin derivative anticoagulants. Br Med J 1982; 285: 274-275
• 22 British Society of Haematology. Guidelines on oral anticoagulation: second edition. J Clin Pathol 1990; 43: 177-183
• 23 Paterson CE, Kwan HC. Current concepts of warfarin therapy. Arch Intern Med 1986; 146: 581-584
• 24 Landelfeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-152
• 25 Gurwitz JH, Avorn J, Ross-Degnan D, Choodnovskiy I, Ansell J. Aging and the anticoagulant response to warfarin therapy. Ann Intern Med 1992; 116: 901-904
• 26 Gurwitz JH, Goldberg RJ, Holden A, Knapic N, Ansell J.. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 1988; 148: 1733-1716